Tenax Therapeutics, Inc.
TENX
$14.60
$0.765.46%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -8.78% | 14.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.12% | 42.52% | |||
| Operating Income | 2.12% | -42.52% | |||
| Income Before Tax | 1.67% | -45.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.67% | -45.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.67% | -45.70% | |||
| EBIT | 2.12% | -42.52% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 4.50% | -45.09% | |||
| Normalized Basic EPS | 4.47% | -45.07% | |||
| EPS Diluted | 4.50% | -45.09% | |||
| Normalized Diluted EPS | 4.47% | -45.07% | |||
| Average Basic Shares Outstanding | 2.96% | 0.43% | |||
| Average Diluted Shares Outstanding | 2.96% | 0.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||